Lu Han 韩路, PhD, is a seasoned professional in the biotechnology and health investment sectors, currently serving as a Partner at Lumira Ventures since 2014. Han has held various roles within the firm, including Principal and Director of Business Development for Asia Pacific. In addition to Lumira Ventures, Han is an active Investor for multiple companies, including the Angelini Lumira Biosciences Fund, Alpha-9 Oncology, Axonis Therapeutics, Cadence Neuroscience Inc., and GenEp. Han also serves as a Board Member for Deka Biosciences and holds Observer roles at Nocion Therapeutics, Thryv Therapeutics Inc., and Iterion Therapeutics. Han earned a Ph.D. in Neuroscience from the University of Toronto, a Bachelor in Medical Sciences from Western University, and completed education at the Rotman School of Management.
This person is not in the org chart
This person is not in any teams
This person is not in any offices